Literature DB >> 16409652

Repeated influenza vaccination of healthy children and adults: borrow now, pay later?

F Carrat1, A Lavenu, S Cauchemez, S Deleger.   

Abstract

A growing number of publications are recommending annual influenza vaccination of healthy children and adults. However, the long-term consequences of repeated influenza vaccination are unknown. We used a simple model of recurrent influenza infection to assess the likely impact of various repeated influenza vaccination scenarios. The model was based on a Markovian framework and was fitted on annual incidence rates of influenza infection by age. We found that natural influenza infection reduced the risk of being re-infected by 15.4% (95% confidence interval 7.1-23.0). Various scenarios of repeated influenza vaccination were then simulated and compared with a reference scenario where vaccination is given from age 65 years onwards. We show that repeated vaccination at a young age substantially increases the risk of influenza in older age, by a factor ranging between 1.2 (vaccination after 50 years) to 2.4 (vaccination from birth). These findings have important implications for influenza vaccination policies.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16409652      PMCID: PMC2870374          DOI: 10.1017/S0950268805005479

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   2.451


  50 in total

1.  Prevention and control of influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP).

Authors:  Carolyn B Bridges; Scott A Harper; Keiji Fukuda; Timothy M Uyeki; Nancy J Cox; James A Singleton
Journal:  MMWR Recomm Rep       Date:  2003-04-25

2.  Recognition of homo- and heterosubtypic variants of influenza A viruses by human CD8+ T lymphocytes.

Authors:  Adrianus C M Boon; Gerrie de Mutsert; Debbie van Baarle; Derek J Smith; Alan S Lapedes; Ron A M Fouchier; Kees Sintnicolaas; Albert D M E Osterhaus; Guus F Rimmelzwaan
Journal:  J Immunol       Date:  2004-02-15       Impact factor: 5.422

3.  Using live, attenuated influenza vaccine for prevention and control of influenza: supplemental recommendations of the Advisory Committee on Immunization Practices (ACIP).

Authors:  Scott A Harper; Keiji Fukuda; Nancy J Cox; Carolyn B Bridges
Journal:  MMWR Recomm Rep       Date:  2003-09-26

4.  Influenza vaccination and reduction in hospitalizations for cardiac disease and stroke among the elderly.

Authors:  Kristin L Nichol; James Nordin; John Mullooly; Richard Lask; Kelly Fillbrandt; Marika Iwane
Journal:  N Engl J Med       Date:  2003-04-03       Impact factor: 91.245

5.  Development and persistence of local and systemic antibody responses in adults given live attenuated or inactivated influenza A virus vaccine.

Authors:  M L Clements; B R Murphy
Journal:  J Clin Microbiol       Date:  1986-01       Impact factor: 5.948

6.  Influenza and the winter increase in mortality in the United States, 1959-1999.

Authors:  Thomas A Reichert; Lone Simonsen; Ashutosh Sharma; Scott A Pardo; David S Fedson; Mark A Miller
Journal:  Am J Epidemiol       Date:  2004-09-01       Impact factor: 4.897

7.  Estimating efficacy of trivalent, cold-adapted, influenza virus vaccine (CAIV-T) against influenza A (H1N1) and B using surveillance cultures.

Authors:  M Elizabeth Halloran; Ira M Longini; Manjusha J Gaglani; Pedro A Piedra; Haitao Chu; Gayla B Herschler; W Paul Glezen
Journal:  Am J Epidemiol       Date:  2003-08-15       Impact factor: 4.897

8.  Protection and compensation in the influenza virus-specific CD8+ T cell response.

Authors:  Richard J Webby; Samita Andreansky; John Stambas; Jerold E Rehg; Robert G Webster; Peter C Doherty; Stephen J Turner
Journal:  Proc Natl Acad Sci U S A       Date:  2003-05-29       Impact factor: 11.205

Review 9.  Influenza virus: immunity and vaccination strategies. Comparison of the immune response to inactivated and live, attenuated influenza vaccines.

Authors:  R J Cox; K A Brokstad; P Ogra
Journal:  Scand J Immunol       Date:  2004-01       Impact factor: 3.487

Review 10.  Current status of live attenuated influenza virus vaccine in the US.

Authors:  Robert B Belshe
Journal:  Virus Res       Date:  2004-07       Impact factor: 3.303

View more
  9 in total

1.  Impact of Repeated Influenza Immunization on Respiratory Illness in Children With Preexisting Medical Conditions.

Authors:  Marieke L A de Hoog; Roderick P Venekamp; Roger A M J Damoiseaux; Anne G M Schilder; Elisabeth A M Sanders; Henriette A Smit; Patricia C J L Bruijning-Verhagen
Journal:  Ann Fam Med       Date:  2019-01       Impact factor: 5.166

2.  High-dose influenza vaccine favors acute plasmablast responses rather than long-term cellular responses.

Authors:  Jin Hyang Kim; H Keipp Talbot; Margarita Mishina; Yuwei Zhu; Jufu Chen; Weiping Cao; Adrian J Reber; Marie R Griffin; David K Shay; Sarah M Spencer; Suryaprakash Sambhara
Journal:  Vaccine       Date:  2016-07-26       Impact factor: 3.641

Review 3.  Universal Influenza Vaccines: Progress in Achieving Broad Cross-Protection In Vivo.

Authors:  Suzanne L Epstein
Journal:  Am J Epidemiol       Date:  2018-12-01       Impact factor: 4.897

4.  Mucosal immunization with a candidate universal influenza vaccine reduces virus transmission in a mouse model.

Authors:  Graeme E Price; Chia-Yun Lo; Julia A Misplon; Suzanne L Epstein
Journal:  J Virol       Date:  2014-03-12       Impact factor: 5.103

5.  Immunity against influenza A(H1N1) infections is determined by age at the time of initial strain circulation.

Authors:  R M Delabre; N Salez; N Lapidus; M Lemaitre; M Leruez-Ville; X de Lamballerie; F Carrat
Journal:  Epidemiol Infect       Date:  2016-09-29       Impact factor: 4.434

6.  Age Dependence of Immunity Induced by a Candidate Universal Influenza Vaccine in Mice.

Authors:  Mayra García; Julia A Misplon; Graeme E Price; Chia-Yun Lo; Suzanne L Epstein
Journal:  PLoS One       Date:  2016-04-07       Impact factor: 3.240

7.  Influenza Vaccination of Healthcare Workers: Critical Analysis of the Evidence for Patient Benefit Underpinning Policies of Enforcement.

Authors:  Gaston De Serres; Danuta M Skowronski; Brian J Ward; Michael Gardam; Camille Lemieux; Annalee Yassi; David M Patrick; Mel Krajden; Mark Loeb; Peter Collignon; Fabrice Carrat
Journal:  PLoS One       Date:  2017-01-27       Impact factor: 3.240

8.  Variation in loss of immunity shapes influenza epidemics and the impact of vaccination.

Authors:  Rutger G Woolthuis; Jacco Wallinga; Michiel van Boven
Journal:  BMC Infect Dis       Date:  2017-09-19       Impact factor: 3.090

9.  Predictive and Reactive Distribution of Vaccines and Antivirals during Cross-Regional Pandemic Outbreaks.

Authors:  Andrés Uribe-Sánchez; Alex Savachkin
Journal:  Influenza Res Treat       Date:  2011-06-05
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.